DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cipro HC Otic (Ciprofloxacin Hydrochloride Otic) - Indications and Dosage

 
 



INDICATIONS AND USAGE

CIPRO® HC OTIC is indicated for the treatment of acute otitis externa in adult and pediatric patients, one year and older, due to susceptible strains of Pseudomonas aeruginosa, Staphylococcus aureus, and Proteus mirabilis.

DOSAGE AND ADMINISTRATION

SHAKE WELL IMMEDIATELY BEFORE USING.

For children (age 1 year and older) and adults, 3 drops of the suspension should be instilled into the affected ear twice daily for seven days. The suspension should be warmed by holding the bottle in the hand for 1-2 minutes to avoid the dizziness which may result from the instillation of a cold solution into the ear canal. The patient should lie with the affected ear upward and then the drops should be instilled. This position should be maintained for 30-60 seconds to facilitate penetration of the drops into the ear. Repeat, if necessary, for the opposite ear. Discard unused portion after therapy is completed.

HOW SUPPLIED

CIPRO® HC OTIC is supplied as a white to off-white opaque suspension in a 10 mL bottle with a dropper dispenser.

NDC 0065-8531-10

Store below 77° F (25° C). Avoid freezing. Protect from light.

U.S. Patent Nos. 5,843,930; 5,965,549.

Licensed to Alcon, Inc. by Bayer Schering Pharma AG.

CIPRO® is a registered trademark of Bayer AG, licensed to Alcon, Inc. by Bayer AG.

Rx Only

Mfd. by:

ALCON CUSI, S.A.

08320 El Masnou - Barcelona

SPAIN

© 2006, 2009 Alcon, Inc.

6-13-932

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017